GAGE1
gene geneOn this page
Also known as CT4.1
Summary
GAGE1 (G antigen 1, HGNC:4098) is a protein-coding gene on chromosome Xp11.23, encoding G antigen 1 (P0DTW1). Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes.
This gene belongs to a family of genes that are expressed in a variety of tumors but not in normal tissues, except for the testis. The sequences of the family members are highly related but differ by scattered nucleotide substitutions. The antigenic peptide YRPRPRRY, which is also encoded by several other family members, is recognized by autologous cytolytic T lymphocytes. Nothing is presently known about the function of this protein. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 2543 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 5 total
- MANE Select transcript:
NM_001040663
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4098 |
| Approved symbol | GAGE1 |
| Name | G antigen 1 |
| Location | Xp11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT4.1 |
| Ensembl gene | ENSG00000205777 |
| Ensembl biotype | protein_coding |
| OMIM | 300594 |
| Entrez | 2543 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 nonsense_mediated_decay
ENST00000381700, ENST00000381709
RefSeq mRNA: 1 — MANE Select: NM_001040663
NM_001040663
CCDS: CCDS43950
Canonical transcript exons
ENST00000381700 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001676190 | 49600167 | 49600258 |
| ENSE00002267134 | 49605993 | 49608538 |
| ENSE00003483988 | 49600724 | 49600844 |
| ENSE00003557786 | 49603668 | 49603793 |
| ENSE00003617584 | 49599020 | 49599127 |
Expression profiles
Bgee: expression breadth broad, 31 present calls, max score 94.16.
Top tissues by expression
198 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 94.16 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 89.02 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.53 | gold quality |
| right testis | UBERON:0004534 | 77.20 | gold quality |
| left testis | UBERON:0004533 | 75.17 | gold quality |
| testis | UBERON:0000473 | 74.75 | gold quality |
| hair follicle | UBERON:0002073 | 61.06 | gold quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| sural nerve | UBERON:0015488 | 55.20 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| stromal cell of endometrium | CL:0002255 | 48.07 | gold quality |
| periodontal ligament | UBERON:0008266 | 47.14 | gold quality |
| renal glomerulus | UBERON:0000074 | 46.86 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 46.77 | gold quality |
| nephron tubule | UBERON:0001231 | 46.71 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 46.70 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 46.19 | gold quality |
| lower lobe of lung | UBERON:0008949 | 45.68 | silver quality |
| dorsal motor nucleus of vagus nerve | UBERON:0002870 | 45.35 | gold quality |
| inferior olivary complex | UBERON:0002127 | 45.14 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 44.31 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 43.37 | gold quality |
| secondary oocyte | CL:0000655 | 42.57 | gold quality |
| medulla oblongata | UBERON:0001896 | 41.74 | gold quality |
| vastus lateralis | UBERON:0001379 | 41.41 | gold quality |
| quadriceps femoris | UBERON:0001377 | 41.37 | gold quality |
| superficial temporal artery | UBERON:0001614 | 41.33 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 40.98 | gold quality |
| jejunal mucosa | UBERON:0000399 | 40.59 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 5.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-3929 | yes | 455.63 |
| E-GEOD-81383 | yes | 150.51 |
| E-CURD-11 | yes | 61.80 |
| E-MTAB-7249 | yes | 11.47 |
| E-ANND-3 | yes | 3.29 |
| E-CURD-53 | no | 717.39 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 5)
- MAGE-A1 and NY-ESO-1 are associated with highly proliferating germ cells, whereas GAGE proteins have a more general function in germ cells unrelated to any specific developmental stage (PMID:17208940)
- Tumor-specific antigen GAGE may play a role in the occurrence and development of ovarian cancer and can be used as one of the important indicators for early diagnosis, efficacy evaluation and prognostic determination of ovarian cancer. (PMID:20423514)
- High GAGE1 expression is associated with metastasis in Head and Neck Squamous Cell Carcinoma. (PMID:29577858)
- The circ_0016760/miR-1287/GAGE1 signaling might play vital roles in the tumorigenesis and progression of Non-small cell lung cancer (NSCLC). (PMID:30103946)
- These data illustrate that the GAGE1 protein exhibits moderate cancerrestricted pattern of expression and immunogenicity, laying the foundation for the application of GAGE1 in immunotherapy and for the diagnosis of HCC[hepatocellular carcinoma]. (PMID:30297572)
Cross-species orthologs
0 orthologs
Paralogs (22): PAGE1 (ENSG00000068985), PAGE4 (ENSG00000101951), XAGE2 (ENSG00000155622), PAGE5 (ENSG00000158639), XAGE3 (ENSG00000171402), XAGE5 (ENSG00000171405), GAGE2A (ENSG00000189064), PAGE3 (ENSG00000204279), XAGE1A (ENSG00000204379), XAGE1B (ENSG00000204382), GAGE12G (ENSG00000215269), GAGE10 (ENSG00000215274), GAGE12E (ENSG00000216649), GAGE12J (ENSG00000224659), GAGE12H (ENSG00000224902), GAGE12D (ENSG00000227488), PAGE2 (ENSG00000234068), GAGE12F (ENSG00000236362), GAGE12C (ENSG00000237671), PAGE2B (ENSG00000238269), GAGE13 (ENSG00000274274), GAGE2E (ENSG00000275113)
Protein
Protein identifiers
G antigen 1 — P0DTW1 (reviewed: P0DTW1)
Alternative names: Antigen MZ2-F, Cancer/testis antigen 4.1
All UniProt accessions (2): P0DTW1, A0A158RFV5
UniProt curated annotations — full annotation on UniProt →
Function. Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes.
Tissue specificity. Expressed in a variety of tumor tissues but not in normal tissues, except testis.
Miscellaneous. This gene belongs to a family of genes organized in clustered repeats. They have a high degree of predicted sequence identity, but differ by scattered single nucleotide substitution. Their sequences contain either the antigenic peptide YYWPRPRRY or YRPRPRRY which is recognized by cytotoxic T-cells.
Similarity. Belongs to the GAGE family.
RefSeq proteins (1): NP_001035753* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008625 | GAGE_fam | Family |
| IPR031320 | GAGE | Domain |
Pfam: PF05831
UniProt features (6 total): compositionally biased region 2, sequence conflict 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DTW1-F1 | 62.61 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 56 (showing top):
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP, SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER, BLALOCK_ALZHEIMERS_DISEASE_UP, LIAO_METASTASIS, HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP, MODULE_113, PIEPOLI_LGI1_TARGETS_UP, MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, AIYAR_COBRA1_TARGETS_UP, BROWNE_HCMV_INFECTION_14HR_UP, LIANG_SILENCED_BY_METHYLATION_2, MODULE_13, chrXp11, MODULE_41
GO Biological Process (1): biological_process (GO:0008150)
GO Molecular Function (2): molecular_function (GO:0003674), protein binding (GO:0005515)
GO Cellular Component (1): cellular_component (GO:0005575)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GAGE8 | WIZ | psi-mi:“MI:0914”(association) | 0.350 |
| GAGE1 | UBB | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A0U1RQG5, A1L429, A6NDE8, A6NER3, A6NGK3, E1AZ71, O08664, O60829, O75459, O76087, P0C2W7, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, P52651, P62521, P86478, P86479, P86480, P86481, P86496, Q13066, Q13069, Q13070, Q17QW4, Q28181, Q2T9P9, Q32PA2, Q4V321, Q4V326, Q5JQC4, Q5U2Y8, Q62100, Q63803, Q64256, Q6NT46, Q6X7S9, Q7Z2X7
Diamond homologs: A1L429, A6NDE8, A6NER3, A6NGK3, O75459, O76087, P0CL80, P0CL81, P0CL82, P0DSO3, P0DTW1, Q13066, Q13069, Q13070, Q4V321, Q4V326, Q6NT46, Q8WTP9, Q96GT9, Q9UEU5, Q8WWM1, Q5JUK9, Q5JRK9, Q7Z2X7, Q9HD64
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
5 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
646 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:49600700:T:A | acceptor_gain | 1.0000 |
| X:49600703:A:AG | acceptor_gain | 1.0000 |
| X:49600704:C:G | acceptor_gain | 1.0000 |
| X:49600705:A:AG | acceptor_gain | 1.0000 |
| X:49600706:C:G | acceptor_gain | 1.0000 |
| X:49600709:A:AG | acceptor_gain | 1.0000 |
| X:49600709:ACAC:A | acceptor_gain | 1.0000 |
| X:49600710:C:G | acceptor_gain | 1.0000 |
| X:49600711:A:AG | acceptor_gain | 1.0000 |
| X:49600711:AC:A | acceptor_gain | 1.0000 |
| X:49600712:C:CA | acceptor_gain | 1.0000 |
| X:49600712:C:G | acceptor_gain | 1.0000 |
| X:49600716:T:G | acceptor_gain | 1.0000 |
| X:49600811:G:GT | donor_gain | 1.0000 |
| X:49600857:G:T | donor_gain | 1.0000 |
| X:49603663:TTAA:T | acceptor_loss | 1.0000 |
| X:49603665:A:AG | acceptor_gain | 1.0000 |
| X:49603665:AAG:A | acceptor_gain | 1.0000 |
| X:49603665:AAGG:A | acceptor_gain | 1.0000 |
| X:49603666:A:G | acceptor_gain | 1.0000 |
| X:49603666:AG:A | acceptor_gain | 1.0000 |
| X:49603666:AGG:A | acceptor_gain | 1.0000 |
| X:49603667:G:GC | acceptor_gain | 1.0000 |
| X:49603667:GG:G | acceptor_gain | 1.0000 |
| X:49603667:GGG:G | acceptor_gain | 1.0000 |
| X:49603667:GGGCC:G | acceptor_gain | 1.0000 |
| X:49603772:G:GT | donor_gain | 1.0000 |
| X:49603790:GAAG:G | donor_gain | 1.0000 |
| X:49603794:G:GA | donor_loss | 1.0000 |
| X:49600165:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
763 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:49600733:T:C | F32L | 0.829 |
| X:49600735:C:A | F32L | 0.829 |
| X:49600735:C:G | F32L | 0.829 |
| X:49600183:G:C | W3C | 0.695 |
| X:49600183:G:T | W3C | 0.695 |
| X:49600192:A:C | R6S | 0.671 |
| X:49600192:A:T | R6S | 0.671 |
| X:49600187:G:A | G5R | 0.662 |
| X:49600187:G:C | G5R | 0.662 |
| X:49600181:T:A | W3R | 0.660 |
| X:49600181:T:C | W3R | 0.660 |
| X:49600182:G:T | W3L | 0.649 |
| X:49600178:A:C | S2R | 0.576 |
| X:49600180:T:A | S2R | 0.576 |
| X:49600180:T:G | S2R | 0.576 |
| X:49600188:G:A | G5E | 0.566 |
dbSNP variants (sampled 300 via entrez): RS1002859072 (X:49607746 C>T), RS1016723267 (X:49608643 G>A), RS1016733137 (X:49608234 G>T), RS1020740167 (X:49607486 C>T), RS1025156111 (X:49607361 T>C), RS1025205633 (X:49607050 C>T), RS1025444825 (X:49609036 C>A), RS1025537953 (X:49608666 T>A,G), RS1029438975 (X:49608197 A>C,G), RS1029904018 (X:49607861 A>G), RS1033759459 (X:49607443 A>C,G), RS1033961998 (X:49607779 A>G,T), RS1037686007 (X:49607640 C>A), RS1037779124 (X:49607262 C>T), RS1038111917 (X:49608998 C>T)
Disease associations
OMIM: gene MIM:300594 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aripiprazole | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Ozone | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.